What is the price of Merck & Co., Inc. (MRK)

The price of Merck & Co., Inc. (MRK) is $115.67

What is the market cap of Merck & Co., Inc. (MRK)

The market cap of Merck & Co., Inc. (MRK) is $285.98B

Merck & Co., Inc. (MRK) P/B Ratio

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Year	P/B Ratio	Change
2026 (TTM)	5.47	7.73%
2025	5.08	-6.51%
2024	5.44	-28.09%
2023	7.56	23.82%
2022	6.11	20.29%
2021	5.08	-34.85%
2020	7.79	-9.22%
2019	8.59	21.37%
2018	7.07	67.90%
2017	4.21	9.48%
2016	3.85	22.74%
2015	3.14	-0.75%
2014	3.16	12.54%
2013	2.81	25.96%
2012	2.23	11.14%
2011	2.01	2.50%
2010	1.96	57.27%
2009	1.24	-62.32%
2008	3.30	-50.09%
2007	6.61	28.29%
2006	5.16	39.08%
2005	3.71	-5.78%
2004	3.93	-37.81%
2003	6.33	-5.53%
2002	6.70	-16.24%
2001	7.99	-42.42%
2000	13.88	0.00%

Year

P/B Ratio

Change

2026 (TTM)

5.47

7.73%

2025

5.08

-6.51%

2024

5.44

-28.09%

2023

7.56

23.82%

2022

6.11

20.29%

2021

5.08

-34.85%

2020

7.79

-9.22%

2019

8.59

21.37%

2018

7.07

67.90%

2017

4.21

9.48%

2016

3.85

22.74%

2015

3.14

-0.75%

2014

3.16

12.54%

2013

2.81

25.96%

2012

2.23

11.14%

2011

2.01

2.50%

2010

1.96

57.27%

2009

1.24

-62.32%

2008

3.30

-50.09%

2007

6.61

28.29%

2006

5.16

39.08%

2005

3.71

-5.78%

2004

3.93

-37.81%

2003

6.33

-5.53%

2002

6.70

-16.24%

2001

7.99

-42.42%

2000

13.88

0.00%

Company	P/B Ratio	P/B Ratio Difference	Country
Eli Lilly LLY.US	33.3372	509.18%	US
AstraZeneca PLC AZN.US	6.0657	10.84%	GB
Johnson & Johnson JNJ.US	7.1931	31.44%	US
AbbVie Inc. ABBV.US	-119.6075	-2,285.61%	US
Novartis AG NVS.US	6.3334	15.73%	CH

Company

P/B Ratio

P/B Ratio Difference

Country